Costin, D.; Burlui, A.M.; Cardoneanu, A.; Macovei, L.A.; Rezus, C.; Bratoiu, I.; Richter, P.; Mihai, I.R.; Gherasim, A.; Danielescu, C.;
et al. Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors. Int. J. Mol. Sci. 2024, 25, 7018.
https://doi.org/10.3390/ijms25137018
AMA Style
Costin D, Burlui AM, Cardoneanu A, Macovei LA, Rezus C, Bratoiu I, Richter P, Mihai IR, Gherasim A, Danielescu C,
et al. Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors. International Journal of Molecular Sciences. 2024; 25(13):7018.
https://doi.org/10.3390/ijms25137018
Chicago/Turabian Style
Costin, Damiana, Alexandra Maria Burlui, Anca Cardoneanu, Luana Andreea Macovei, Ciprian Rezus, Ioana Bratoiu, Patricia Richter, Ioana Ruxandra Mihai, Andreea Gherasim, Ciprian Danielescu,
and et al. 2024. "Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors" International Journal of Molecular Sciences 25, no. 13: 7018.
https://doi.org/10.3390/ijms25137018
APA Style
Costin, D., Burlui, A. M., Cardoneanu, A., Macovei, L. A., Rezus, C., Bratoiu, I., Richter, P., Mihai, I. R., Gherasim, A., Danielescu, C., & Rezus, E.
(2024). Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors. International Journal of Molecular Sciences, 25(13), 7018.
https://doi.org/10.3390/ijms25137018
